Markova, M. and Hristov, G. (2023) “Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies”, Research Papers, (4), pp. 57–65. doi:https://doi.org/10.37075/RP.2022.4.04.